Drug Discovery · Del Mar, CA · Founded 2014 · Privately Held (backing)
Developer of a eyecare medicine and drug designed to treat myopia. Sydnexis is based in Del Mar, CA and was founded in 2014. Its last reported valuation was $90 million in Aug 2021. It has raised $76.5 million across 4 recorded rounds; the latest was a $20 million early-stage round in Apr 2025.
Last reported valuation
$90.0M
Oct 2026
Priced at
—
Total raised
$76.5M
Last round
Early Stage VC
Apr 2025
Cap table — not yet on record
Sydnexis's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sydnexis with a free account
·Watch Sydnexis: the Monday email on marks, rounds and moves